Urology
Volume 72, Issue 6 , Pages 1224-1228 , December 2008

Prognostic Significance of Cancer Volume Involving Seminal Vesicles in Patients With pT3bpN0 Prostate Cancer

  • Shinya Yamamoto

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • Corresponding Author InformationReprint requests: Shinya Yamamoto, M.D., Ph.D., Department of Urology, Cancer Institute Hospital, 3-10-6, Ariake, Koto-ku, Tokyo 135-8550 Japan
    • ,
  • Satoru Kawakami

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Junji Yonese

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Yasuhisa Fujii

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Tetsuro Tsukamoto

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Yuhei Ohkubo

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Yoshinobu Komai

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Yuichi Ishikawa

      Affiliations

    • Department of Pathology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan
    • ,
  • Iwao Fukui

      Affiliations

    • Department of Urology, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan

Received 1 April 2008 ,Accepted 28 June 2008.

References 

  1. Secin FP, Bianco FJ, Vickers AJ, et al. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy. Cancer. 2006;106:2369–2375
  2. Tefilli MV, Gheiler EL, Tiguert R, et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol. 1998;160:802–806
  3. Sofer M, Savoie M, Kim SS, et al. Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol. 2003;169:153–156
  4. Salomon L, Anastasiadis AG, Johnson CW, et al. Seminal vesicle involvement after radical prostatectomy: Predicting risk factors for progression. Urology. 2003;62:304–309
  5. Freedland SJ, Aronson WJ, Presti JC, et al. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer. 2004;100:1633–1638
  6. Graham SD, Napalkov P, Watts L, et al. Microvascular invasion of the seminal vesicle in adenocarcinoma of the prostate. Prostate. 1996;28:359–363
  7. Baccala A, Reuther AM, Bianco FJ, et al. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: Multi-institutional study of 6740 Patients. Urology. 2007;69:536–540
  8. Sobin LH, Wittekind CH International Union Against Cancer. Urologic tumors, prostate. In:  Sobin LH,  Wittekind CH editor. TNM Classification of Malignant Tumors. 6th ed.. New York: John Wiley & Sons; 2002;p. 170–173
  9. Kawakami S, Fukui I, Yonese J, et al. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients. Jpn J Clin Oncol. 2007;37:528–533
  10. Yamamoto S, Yonese J, Kawakami S, et al. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol. 2007;52:696–701
  11. Epstein JI, Carmichael M, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993;149:1040–1045
  12. Mazzucchelli R, Montironi R, Prezioso D, et al. Surgical pathology examination of radical prostatectomy specimens (Updated protocol based on the Italian TAP Study). Anticancer Res. 2001;21:3599–3608
  13. Ohori M, Scardino PT, Lapin SL, et al. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol. 1993;17:1252–1261
  14. Renshow AA, Richie JP, Loughlin KR, et al. Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens: Validation in a cohort of 434 patients. Am J Clin Pathol. 1999;111:641–644
  15. Debras B, Guillonneau B, Bougaran J, et al. Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Eur Urol. 1998;33:271–277
  16. Epstein JI, Partin AW, Potter SR, et al. Adenocarcinoma of the prostate invading the seminal vesicle: Prognostic stratification based on pathologic parameters. Urology. 2000;56:283–288
  17. Villers AA, Mcneal JE, Redwine EA, et al. Pathogenesis and biological invasion in prostatic adenocarcinoma. J Urol. 1990;143:1183–1187
  18. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA. 2006;296:2329–2335
  19. Bolla M, Poppel HV, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911). Lancet. 2005;366:572–578
  20. Zincke H, Lan W, Bergstraeh E, et al. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. J Urol. 2001;166:2208–2215

PII: S0090-4295(08)00849-2

doi: 10.1016/j.urology.2008.06.055

Urology
Volume 72, Issue 6 , Pages 1224-1228 , December 2008

Article Tools

* Image Usage & Resolution